Angiosarcomas of the pulmonary artery are rare and carry a very poor prognosis. We describe the case of a patient with pulmonary artery angiosarcoma who underwent radical resection followed by chemotherapy and was alive after 6 years of follow-up. Our case demonstrates that a multidisciplinary approach including cardiac diagnostics, radical surgery, and effective adjuvant chemoradiotherapy can improve outcome.
BlackmonSHRiceDCCorreaAMMehranRPutnamJBSmytheWR. Management of primary pulmonary artery sarcomas [Review]. Ann Thorac Surg2009; 87: 977–984.
2.
SchlemmerMReichardtPVerweijJHartmannJTJudsonIThyssA. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer2008; 44: 2433–2436.
3.
PenelNBuiBNBayJOCupissolDRay-CoquardIPiperno-NeumannS. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol2008; 26: 5269–5274.
4.
GrimerRJudsonIPeakeDSeddonB. Guidelines for the management of soft tissue sarcomas. Sarcoma2010; 2010: 506182–506182.
5.
Llombart-CussacAPivotXContessoGRhor-AlvaradoADelordJPSpielmannM. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer1998; 78: 1624–1628.
